This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things
Journal of Translational Medicine Open Access 07 June 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Li, Q. J. et al. Hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin versus transarterial chemoembolization for large hepatocellular carcinoma: a randomized phase III trial. J. Clin. Oncol. https://doi.org/10.1200/JCO.21.00608 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidaway, P. FOLFOX–HAIC active in large HCC. Nat Rev Clin Oncol 19, 5 (2022). https://doi.org/10.1038/s41571-021-00577-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-021-00577-y
This article is cited by
-
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things
Journal of Translational Medicine (2023)